These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3840014)

  • 1. Positional effects on exophthalmometer readings in Graves' eye disease.
    Frueh BR; Garber F; Grill R; Musch DC
    Arch Ophthalmol; 1985 Sep; 103(9):1355-6. PubMed ID: 3840014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postural variation of exophthalmometry in Graves' ophthalmopathy.
    Asad R; Tewari HK; Ahuja MM; Mithal A
    Indian J Ophthalmol; 1990; 38(4):166-8. PubMed ID: 2086467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Graves' eye disease on levator muscle function.
    Frueh BR; Garber FW; Musch DC
    Ophthalmic Surg; 1986 Mar; 17(3):142-5. PubMed ID: 3754320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exophthalmometer readings in patients with Graves' eye disease.
    Frueh BR; Musch DC; Garber FW
    Ophthalmic Surg; 1986 Jan; 17(1):37-40. PubMed ID: 3754041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study.
    Mourits MP; Lombardo SH; van der Sluijs FA; Fenton S
    Orbit; 2004 Sep; 23(3):161-8. PubMed ID: 15545129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
    Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
    Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The measurement of change in Graves' ophthalmopathy.
    Gorman CA
    Thyroid; 1998 Jun; 8(6):539-43. PubMed ID: 9669294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motility disturbances in Graves' ophthalmopathy.
    de Waard R; Koornneef L; Verbeeten B
    Doc Ophthalmol; 1983 Dec; 56(1-2):41-7. PubMed ID: 6689301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of eye movement to computed tomographic findings in patients with Graves' ophthalmopathy.
    Chen YL; Chang TC; Huang KM; Tzeng SS; Kao SC
    Acta Ophthalmol (Copenh); 1994 Aug; 72(4):472-7. PubMed ID: 7825416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of ocular changes, extraocular muscle thickness, and eye movements in Graves' ophthalmopathy.
    Jankauskiene J; Imbrasiene D
    Medicina (Kaunas); 2006; 42(11):900-3. PubMed ID: 17172791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy.
    Gamblin GT; Harper DG; Galentine P; Buck DR; Chernow B; Eil C
    N Engl J Med; 1983 Feb; 308(8):420-4. PubMed ID: 6687400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinico-investigative profile in Graves' ophthalmopathy.
    Khurana AK; Sunder S; Ahluwalia BK; Malhotra KC; Gupta S
    Indian J Ophthalmol; 1992; 40(2):56-8. PubMed ID: 1452284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease: measurement of the extraocular muscle thickness with the echobiometer.
    Schenome M; Polizzi A; Buono C; Ciurlo C
    Ophthalmologica; 1998; 212 Suppl 1():104-6. PubMed ID: 9730769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital compliance in Graves' eye disease.
    Frueh BR; Musch DC; Grill R; Garber FW; Hamby S
    Ophthalmology; 1985 May; 92(5):657-65. PubMed ID: 3839299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' ophthalmopathy: I. Simple CT estimates of extraocular muscle volume.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):674-7. PubMed ID: 3179254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between NMR scans of extraocular muscles and clinical symptoms in Graves' ophthalmopathy.
    Troelstra A; Rijneveld WJ; Kooijman AC; Houtman WA
    Doc Ophthalmol; 1988; 70(2-3):243-9. PubMed ID: 3234192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.